AJP - Heart AJP: Heart and Circulatory Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (June 8, 2007). doi:10.1152/ajpheart.00393.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/3/H1351    most recent
00393.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Basso, N.
Right arrow Articles by Inserra, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Basso, N.
Right arrow Articles by Inserra, F.
Submitted on March 29, 2007
Accepted on June 4, 2007

CARDIOVASCULAR AGING: PROTECTIVE EFFECT OF LONG-TERM ANGIOTENSIN II INHIBITION

Nidia Basso1*, Rosa Cini2, Adriana Pietrelli3, Leon Ferder4, Norberto Antonio Terragno5, and Felipe Inserra6

1 Pathology, School of Medicine. University of Buenos Aires., Buenos Aires, Argentina
2 Pharmacology, School of Veterinarian Medicine. University of Buenos Aires, Buenos Aires, Argentina
3 Pathology, School of Medicine. University of Buenos Aires, Buenos Aires, Argentina
4 Physiology and Pharmacology, Ponce School of Medicine, Ponce, Puerto Rico
5 Pharmacology, School of Medicine. University of Buenos Aires, Buenos Aires, Argentina
6 Institute of Cardiologic Research, School of Medicine. University of Buenos Aires, Buenos Aires, Argentina

* To whom correspondence should be addressed. E-mail: nidiabasso{at}yahoo.com.

Experimental studies indicate that angiotensin II (Ang II) through its type 1 receptor (AT1) promotes cardiovascular hypertrophy and fibrosis. Therefore, the aim of this study was to analyze if chronic long-term inhibition of the renin-angiotensin system (RAS) can prevent most of the deleterious effects due to aging in the cardiovascular system of the normal rat. All the information available on this subject provided by several studies performed by our research group during the last years is been described. A control group remained untreated; treatment was initiated two weeks after weaning. A converting enzyme inhibitor: enalapril (10 mg/kg/day) or an AT1 receptor blocker: losartan (30 mg/kg/day) were used to inhibit the RAS. Systolic blood pressure, body weight, water and food intake were recorded along the whole experimental period. Heart, aorta and mesenteric artery weight as well as histological analysis of cardiovascular structure were performed at 6 and 18 months. Twenty animals of each of the three experimental groups were allowed to die spontaneously. Results have demonstrated a significant protective effect on the function and the structure of the cardiovascular system in all the treated animals. Changes observed at 18 months of age in the hearts and aortas were quite significant, but each treatment completely abolished this deterioration. The similarity between the results detected with either enalapril or losartan treatment, clearly indicates that most of the effects are exerted through AT1 receptors. Moreover, life span was significantly prolonged in both groups of treated animals compared with untreated controls.




This article has been cited by other articles:


Home page
Circ. Res.Home page
K. Gusev, A. A. Domenighetti, L. M.D. Delbridge, T. Pedrazzini, E. Niggli, and M. Egger
Angiotensin II-Mediated Adaptive and Maladaptive Remodeling of Cardiomyocyte Excitation-Contraction Coupling
Circ. Res., July 2, 2009; 105(1): 42 - 50.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Z. Fu, M. Wang, M. Gucek, J. Zhang, J. Wu, L. Jiang, R. E. Monticone, B. Khazan, R. Telljohann, J. Mattison, et al.
Milk Fat Globule Protein Epidermal Growth Factor-8: A Pivotal Relay Element Within the Angiotensin II and Monocyte Chemoattractant Protein-1 Signaling Cascade Mediating Vascular Smooth Muscle Cells Invasion
Circ. Res., June 19, 2009; 104(12): 1337 - 1346.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D.-F. Dai, L. F. Santana, M. Vermulst, D. M. Tomazela, M. J. Emond, M. J. MacCoss, K. Gollahon, G. M. Martin, L. A. Loeb, W. C. Ladiges, et al.
Overexpression of Catalase Targeted to Mitochondria Attenuates Murine Cardiac Aging
Circulation, June 2, 2009; 119(21): 2789 - 2797.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. L. Modrick, S. P. Didion, C. D. Sigmund, and F. M. Faraci
Role of oxidative stress and AT1 receptors in cerebral vascular dysfunction with aging
Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1914 - H1919.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. M. de Cavanagh, M. Ferder, F. Inserra, and L. Ferder
Angiotensin II, mitochondria, cytoskeletal, and extracellular matrix connections: an integrating viewpoint
Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H550 - H558.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.